NEW YORK (Reuters Health) – Two independent studies have shown that long-term outcomes are better with radiotherapy and chemotherapy rather than radiotherapy alone in patients with anaplastic oligodendrogliomas…
Oriane Chausiaux, PhD, and Shamus Husheer, PhD, discuss DuoFertility, a new method to aid couples struggling with infertility. The program monitors over 20,000 physiological measurements to guide couples on the best ways to conceive…
NEW YORK (Reuters Health) – A test that measures levels of the protein fibulin-3 in blood and pleural fluid can identify people with pleural mesothelioma and might someday…
NEW YORK (Reuters Health) – A retrospective multicenter study conducted in France concludes that combination chemotherapy with gemcitabine and oxaliplatin is effective in patients with advanced hepatocellular carcinoma…
NEW YORK (Reuters Health) – Compared to open radical prostatectomy in patients with recurrent prostate cancer after failed primary therapy, robotic-assisted laparoscopic prostatectomy “is an attractive alternative”, and…
NEW YORK (Reuters Health) – Whole-body (WB) scans using either magnetic resonance imaging (MRI) or positron-emission tomography (PET) with CT, both have high sensitivity and specificity in detecting…
NEW YORK (Reuters Health) – The theoretical advantage of a retrograde rather than antegrade approach to nerve sparing during robot-assisted radical prostatectomy (RARP) has been confirmed in a…
NEW YORK (Reuters Health) – After platinum failure in patients with advanced non-small-cell lung cancer, adding aflibercept to standard second-line docetaxel treatment does not improve overall survival (OS),…
NEW YORK (Reuters Health) – In the first-line treatment of advanced colorectal cancer, the combination of cediranib and chemotherapy is comparable to bevacizumab plus chemotherapy in terms of…
NEW YORK (Reuters Health) – The risk of developing lung cancer is significantly lower in people with excess body weight compared to those of normal weight, according to…
